Champions Oncology (CSBR) Gross Margin Growth (3y) (2020 - 2026)
Champions Oncology (CSBR) Gross Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -230.00 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -168.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -65.00 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 14,836.00 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 589.00 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 53.00 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 569.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -3,244.00 |
| 10 | Champions Oncology | 71.17 Mn | 71.17 Mn | 7.03 Mn | 692.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 692.00 |
| Jan 31, 2026 | 693.00 |
| Oct 31, 2025 | 382.00 |
| Jul 31, 2025 | -582.00 |
| Apr 30, 2025 | -1,054.00 |
| Jan 31, 2025 | 972.00 |
| Oct 31, 2024 | -748.00 |
| Jul 31, 2024 | -234.00 |
| Apr 30, 2024 | 353.00 |
| Jan 31, 2024 | -2,255.00 |
| Oct 31, 2023 | -140.00 |
| Jul 31, 2023 | -528.00 |
| Apr 30, 2023 | 150.00 |
| Jan 31, 2023 | -1,228.00 |
| Oct 31, 2022 | -122.00 |
| Jul 31, 2022 | 439.00 |
| Jan 31, 2022 | 477.00 |
| Oct 31, 2021 | 397.00 |
| Jul 31, 2021 | 157.00 |
| Jan 31, 2021 | 590.00 |